Treat Frown Lines, Forehead Lines, and Crow's Feet
All in One Visit

Xeomin® (incobotulinumtoxinA) is a botulinum toxin type A injectable in the same drug class as Botox and Dysport. The FDA first approved Xeomin for moderate to severe glabellar lines - the vertical "11" lines between the brows - in 2011. In July 2024, Xeomin became the first and only U.S. neurotoxin approved for the simultaneous treatment of all three upper facial line areas: frown lines, forehead lines, and crow's feet.Merz Aesthetics manufactures Xeomin. What sets it apart from other wrinkle relaxers is its production process.

Merz uses XTRACT Technology to double-filter the formula, removing the complexing proteins found in other botulinum toxin products. The result is a 3-ingredient product containing only botulinum toxin type A, human albumin, and sucrose. At New Day Medspa, Xeomin is injected by licensed ARNPs and PAs who treat upper facial lines daily in Jacksonville, FL.

Xeomin blocks the nerve signals that tell specific facial muscles to contract. Less movement in those muscles means the skin above stops folding into a crease every time you frown, squint, or raise your brows.

What makes Xeomin different is what it leaves out. Most botulinum toxin products contain complexing proteins alongside the active toxin. Merz's XTRACT Technology filters those out, leaving a cleaner formula. In the clinical trials submitted for FDA approval, no patients developed a secondary lack of response due to neutralizing antibodies - a meaningful difference for anyone planning to keep up with treatments long-term.

Results typically appear within a few days and settle fully over the following 2 weeks. They generally last 3 to 4 months. Xeomin should not be re-injected more frequently than every 3 months.

Xeomin brings a double-filtered formula and consistent results at $9.99 per unit - a strong value for a neurotoxin FDA-approved for all three upper facial line areas.